Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Roigas

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Der Urologe. Ausg. A|December 6, 2005
[Ten years of laparoscopic living kidney donation. From an extravagant to a routine procedure]M Giessing, T F Fuller, S Deger, et al.
World Journal of Urology|December 16, 2006
Fast-track surgery in laparoscopic radical prostatectomy: basic principlesO Gralla, F Haas, N Knoll, et al.
Cancer Research|June 30, 2001
Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomasM S Wiesener, P M Münchenhagen, I Berger, et al.
British Journal of Cancer|August 16, 2006
Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)J Atzpodien, H Kirchner, U Rebmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2004
Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)J Atzpodien, H Kirchner, U Jonas, et al.
International Urology and Nephrology|November 30, 2016
Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 databaseM May, C Protzel, M W Vetterlein, et al.
Folia Biologica|December 19, 2003
Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome studyE Huland, A Burger, J Fleischer, et al.
Der Urologe. Ausg. A|October 6, 2010
[Patients with bladder cancer in clinical stage T2 : survival benefit of downstaging in comparison to patients with confirmed muscle invasion in cystectomy specimens]M May, H-M Fritsche, S Brookman-May, et al.
World Journal of Urology|June 6, 2013
Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validationM Gierth, H M Fritsche, H Buchner, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 8, 2013
Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networksA Buchner, M May, M Burger, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Der Urologe. Ausg. A|December 6, 2005
[Ten years of laparoscopic living kidney donation. From an extravagant to a routine procedure]M Giessing, T F Fuller, S Deger, et al.
World Journal of Urology|December 16, 2006
Fast-track surgery in laparoscopic radical prostatectomy: basic principlesO Gralla, F Haas, N Knoll, et al.
Cancer Research|June 30, 2001
Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomasM S Wiesener, P M Münchenhagen, I Berger, et al.
British Journal of Cancer|August 16, 2006
Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)J Atzpodien, H Kirchner, U Rebmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2004
Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)J Atzpodien, H Kirchner, U Jonas, et al.
International Urology and Nephrology|November 30, 2016
Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 databaseM May, C Protzel, M W Vetterlein, et al.
Folia Biologica|December 19, 2003
Efficacy and safety of inhaled recombinant interleukin-2 in high-risk renal cell cancer patients compared with systemic interleukin-2: an outcome studyE Huland, A Burger, J Fleischer, et al.
Der Urologe. Ausg. A|October 6, 2010
[Patients with bladder cancer in clinical stage T2 : survival benefit of downstaging in comparison to patients with confirmed muscle invasion in cystectomy specimens]M May, H-M Fritsche, S Brookman-May, et al.
World Journal of Urology|June 6, 2013
Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validationM Gierth, H M Fritsche, H Buchner, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 8, 2013
Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networksA Buchner, M May, M Burger, et al.
Pageof 6